Condition: CIDP · Immunoglobulin Deficiency · Chronic Inflammatory Demyelinating Polyneuropathy · Sponsor: Rutgers, The State University of New Jersey
Current dosing practices for immunoglobulin G (IgG) may be inadequate in extreme body weight. The current study will evaluate the influence of body composition on intravenous and subcutaneous administration of immunoglobulin G in patients.
This description comes directly from the study's public registry record.
Luigi Brunetti, PhD · 2016385868 · brunetti@pharmacy.rutgers.edu
Always discuss trial participation with your own doctor first.
| Rutgers, The State University of New Jersey Clinical Research Center | New Brunswick, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05584631